Apheresis Market Revenues to Reach USD 4.37 billion by 2028 – Market Size, Share, Forecasts, & Trends Analysis Report by Mordor Intelligence
Hyderabad, Aug. 02, 2023 (GLOBE NEWSWIRE) — According to a new market research report titled “Apheresis Market Report (2023-2028),” the market is estimated at USD 3.33 billion in 2023. It is expected to register a CAGR of 5.63% during the forecast period.
Apheresis is a medical technique that involves passing blood through an apparatus to separate a specific component and return the rest to the bloodstream. Apheresis is used in treating various diseases, such as thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, autoimmune diseases, and sepsis. The increasing burden of diseases, rising demand for blood components and safety, technological advancements, and improved reimbursement policies and funding for apheresis procedures are driving the global apheresis market.
Report Summary:
| Report Attribute | Details |
| Market Size (2023) | USD 3.33 billion |
| Market Size (2028) | USD 4.37 billion |
| CAGR (2023-2028) | 5.63% |
| Study Period | 2018-2028 |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Forecast Units | Value (USD billion) |
| Report Scope | Market Dynamics, Revenue Forecast and Segmentation, Competitive Landscape and Recent Developments, Market Growth, Future Opportunities, and Trends |
| Key Market Drivers | Increasing product innovations and approvals. |
| The increasing burden of diseases and rising demand for blood components. |
Who are the Top Companies in the Global Apheresis Market?
The market is moderately competitive and dominated by a few major players. Currently, the market is well-established in many areas and has shown nascent success. However, its full potential is yet to be determined in developing regions. Strategic alliances and product launches by major companies and government initiatives are expected to drive the growth of the market in the coming years.
The significant players in the global apheresis market are,
- Asahi Kasei Corporation
- B. Braun SE
- Fresenius SE & Co. KGAA (Fresenius Kabi AG)
- Haemonetics Corporation
- Terumo Corporation (Terumo BCT Inc.)
- Kaneka Corporation
- Sumitomo Bakelite Company Limited (Kawasumi Laboratories Inc.)
- Medica SPA
- Baxter International
- Cerus Corporation
- Macopharma SA
- Otsuka Holdings Co. Ltd (JIMRO Co. Ltd)
Other Reports That Might Be of Your Interest:
- Dried Blood Spot Collection Cards Market Report – The dried blood spot collection cards market is expected to register a CAGR of 3.1% over the next five years.
- Blood Collection Market Report – The blood collection market is expected to register a CAGR of 6.2% over the next five years.
Key Highlights from the Global Apheresis Market Report:
Growing Hematological Disorders Segment
- Hematologic disorders involve problems with blood and blood-forming organs, leading to significant morbidity and mortality worldwide. Sickle cell disease (SCD) affects approximately 100,000 Americans. Apheresis is increasingly used as a treatment method for hematological disorders.
- Therapeutic apheresis techniques like immunoadsorption, double filtration, and cytapheresis are used in treating both primary and secondary autoimmune renal diseases. Apheresis plays a vital role in managing sickle cell anemia, providing better red cell exchange therapeutic procedures for patients.
- Numerous clinical trials and studies are investigating the use of apheresis for hematological malignancies and other hematological diseases.
Steady Growth in North America
- North America is expected to witness growth in the apheresis market due to the increasing burden of blood-related ailments and neurological disorders.
- The established healthcare infrastructure and high patient awareness levels are boosting the market’s growth in the region. The high incidence of target diseases, such as leukemia, lymphoma, and myeloma, is driving the demand for apheresis procedures and devices in the United States.
- Increasing reimbursement policies for apheresis procedures and devices is also contributing to the growth of the market.
What are the Latest Developments in the Global Apheresis Market?
- In July 2022, Terumo Blood and Cell Technologies collaborated with Eliaz Therapeutics to develop and commercialize a novel therapeutic apheresis treatment for acute kidney injury (AKI).
- In June 2022, Terumo Blood and Cell Technologies reported that the UK’s NHS England has selected the automated red blood cell exchange (RBCX) procedure performed on the company’s Spectra Optia Apheresis System through the NHS MedTech Funding Mandate (MTFM) to treat sickle cell disease.
Mordor Intelligence has Segmented the Global Apheresis Market Based on Product, Apheresis Procedure, Technology, Application, and Geography.
- By Product (Market Size and Forecast based on Value (USD billion), 2018-2028)
- Devices
- Disposables
- By Apheresis Procedure (Market Size and Forecast based on Value (USD billion), 2018-2028)
- Leukapheresis
- Plasmapheresis
- Plateletpheresis
- Erythrocytapheresis
- Other Apheresis Procedures
- By Technology (Market Size and Forecast based on Value (USD billion), 2018-2028)
- Centrifugation
- Membrane Separation
- By Application (Market Size and Forecast based on Value (USD billion), 2018-2028)
- Renal Disorders
- Hematological Disorders
- Neurological Disorders
- Autoimmune Disorders
- Other Applications
- By Geography (Market Size and Forecast based on Value (USD billion), 2018-2028)
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
In a nutshell, the Mordor Intelligence market research report is a must-read for start-ups, industry players, investors, researchers, consultants, business strategists, and all those who are looking to understand this industry. Get a glance at the Global Apheresis Market Report (2023-2028).
Mordor Intelligence constantly tracks industry trends. Some relevant market reports from the analysts that might be of interest to you:
- Blood Ketone Meter Market Report – The blood ketone meter market is projected to register a CAGR of 6.7% over the next five years.
- Blood Transfusion Diagnostics Market Report – The blood transfusion diagnostics market is expected to register a CAGR of 6.9% over the next five years.
- Blood Bank Market Report – The blood bank market is expected to register a CAGR of 5.20% over the next five years.
About Mordor Intelligence:
Mordor Intelligence is a market intelligence and advisory firm. At Mordor Intelligence, we believe in predicting butterfly effects that have the potential to change or significantly impact market dynamics.
Our market research reports are comprehensive and provide exclusive data, facts and figures, trends, and the competitive landscape of the industry.
Attachment
CONTACT: Company Name: Mordor Intelligence Email: info@mordorintelligence.com Phone: +1 617-765-2493 Location: Hyderabad, Telangana Country: India
